Elevation Oncology Faces Delisting Notice

Elevation Oncology, Inc. 8-K Filing Summary
FieldDetail
CompanyElevation Oncology, Inc.
Form Type8-K
Filed DateMar 19, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, regulatory

TL;DR

Elevation Oncology might get delisted - big trouble ahead.

AI Summary

Elevation Oncology, Inc. filed an 8-K on March 19, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as 14ner Oncology, Inc. and is incorporated in Delaware.

Why It Matters

This filing indicates potential issues with Elevation Oncology's continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards suggests significant financial or operational distress, posing a substantial risk to the company and its investors.

Key Numbers

  • 001-40523 — SEC File Number (Identifies the company's filings with the SEC.)
  • 84-1771427 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • Elevation Oncology, Inc. (company) — Registrant
  • March 19, 2025 (date) — Date of Report
  • 14ner Oncology, Inc. (company) — Former Company Name
  • Delaware (jurisdiction) — State of Incorporation
  • 001-40523 (identifier) — SEC File Number

FAQ

What specific listing rule or standard has Elevation Oncology failed to satisfy?

The filing does not specify the exact rule or standard that Elevation Oncology has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is March 19, 2025.

What was Elevation Oncology, Inc. formerly known as?

Elevation Oncology, Inc. was formerly known as 14ner Oncology, Inc.

In which state is Elevation Oncology, Inc. incorporated?

Elevation Oncology, Inc. is incorporated in Delaware.

What is the principal executive office address for Elevation Oncology, Inc.?

The principal executive offices are located at 101 Federal Street, Suite 1900, Boston, Massachusetts 02110.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Elevation Oncology, Inc..

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.